Skip to main content
Top
Published in: Cancer Cell International 1/2002

Open Access 01-12-2002 | Primary research

Real-time RT-PCR analysis of mRNA decay: half-life of Beta-actin mRNA in human leukemia CCRF-CEM and Nalm-6 cell lines

Authors: Guy J Leclerc, Gilles M Leclerc, Julio C Barredo

Published in: Cancer Cell International | Issue 1/2002

Login to get access

Abstract

Background

We describe an alternative method to determine mRNA half-life (t1/2) based on the Real-Time RT-PCR procedure. This approach was evaluated by using the β-actin gene as a reference molecule for measuring of mRNA stability.

Results

Human leukemia Nalm-6 and CCRF-CEM cells were treated with various concentrations of Actinomycin D to block transcription and aliquots were removed periodically. Total RNA was isolated and quantified using the RiboGreen® fluorescent dye with the VersaFluor Fluorometer System. One μg of total RNA was reverse transcribed and used as template for the amplification of a region of the β-actin gene (231 bp). To generate the standard curve, serial ten-fold dilutions of the pBactin-231 vector containing the cDNA amplified fragment were employed, β-actin mRNAs were quantified by Real-Time RT-PCR using the SYBR® Green I fluorogenic dye and data analyzed using the iCycle iQ system software. Using this method, the β-actin mRNA exhibited a half-life of 6.6 h and 13.5 h in Nalm-6 and CCRF-CEM cells, respectively. The t1/2 value obtained for Nalm-6 is comparable to those estimated from Northern blot studies, using normal human leukocytes (5.5 h).

Conclusions

We have developed a rapid, sensitive, and reliable method based on Real-Time RT-PCR for measuring mRNA half-life. Our results confirm that β-actin mRNA half-life can be affected by the cellular growth rate.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wilkinson DG: In Situ Hybridization. A Practical Approach. Oxford University Press, New York. 1992 Wilkinson DG: In Situ Hybridization. A Practical Approach. Oxford University Press, New York. 1992
2.
go back to reference Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning. A Laboratory Manual. 1989, CSJ Laboratory Press, Cold Spring Harbor, New York, 2 Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning. A Laboratory Manual. 1989, CSJ Laboratory Press, Cold Spring Harbor, New York, 2
4.
go back to reference de Mercoyrol L, Job C, Job D: Studies on the inhibition by alpha-amanitin of single-step addition reactions and productive RNA synthesis catalyzed by wheat-germ RNA polymerase II. Biochem. J. 1989, 258: 165-169.PubMedCentralCrossRefPubMed de Mercoyrol L, Job C, Job D: Studies on the inhibition by alpha-amanitin of single-step addition reactions and productive RNA synthesis catalyzed by wheat-germ RNA polymerase II. Biochem. J. 1989, 258: 165-169.PubMedCentralCrossRefPubMed
5.
go back to reference Egyhazi E: Initiation inhibition and re-initiation of the synthesis of heterogeneous nuclear RNA in living cells. Nature. 1976, 262: 319-321.CrossRefPubMed Egyhazi E: Initiation inhibition and re-initiation of the synthesis of heterogeneous nuclear RNA in living cells. Nature. 1976, 262: 319-321.CrossRefPubMed
6.
go back to reference Higuchi R, Fockler C, Dollinger G, Watson R: Kinetic PCR: Real time monitoring of DNA amplification reactions. Biotechnology. 1993, 11: 1026-1030.CrossRefPubMed Higuchi R, Fockler C, Dollinger G, Watson R: Kinetic PCR: Real time monitoring of DNA amplification reactions. Biotechnology. 1993, 11: 1026-1030.CrossRefPubMed
7.
go back to reference Gibson UEM, Heid CA, Williams PM: A novel method for real-time quantitative RT-PCR. Genome Res. 1996, 6: 995-1001.CrossRefPubMed Gibson UEM, Heid CA, Williams PM: A novel method for real-time quantitative RT-PCR. Genome Res. 1996, 6: 995-1001.CrossRefPubMed
8.
go back to reference Heid C, Stevens J, Livak K, Williams PM: Real time quantitative PCR,. Genome Res. 1996, 6: 986-994.CrossRefPubMed Heid C, Stevens J, Livak K, Williams PM: Real time quantitative PCR,. Genome Res. 1996, 6: 986-994.CrossRefPubMed
9.
go back to reference Bravo R, Celis JE: A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells. J. Cell Biol. 1980, 84: 795-802.CrossRefPubMed Bravo R, Celis JE: A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells. J. Cell Biol. 1980, 84: 795-802.CrossRefPubMed
10.
go back to reference Galpin AJ, Schuetz JD, Masson E, Yanishevski Y, Synold TW, Barredo JC, Pui CH, Relling MV, Evans WE: Differences in Folylpolyglutamate Synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicity. Mol. Pharmacol. 1997, 52: 155-163.PubMed Galpin AJ, Schuetz JD, Masson E, Yanishevski Y, Synold TW, Barredo JC, Pui CH, Relling MV, Evans WE: Differences in Folylpolyglutamate Synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicity. Mol. Pharmacol. 1997, 52: 155-163.PubMed
11.
go back to reference Wadkins RM, Jares-Erijman EA, Klement R, Rudiger A, Jovin TM: Actinomycin D binding to single-stranded DNA: sequence specificity and hemi-intercalation model from fluorescence and 1H NMR spectroscopy. J. Mol. Biol. 1996, 262: 53-68. 10.1006/jmbi.1996.0498.CrossRefPubMed Wadkins RM, Jares-Erijman EA, Klement R, Rudiger A, Jovin TM: Actinomycin D binding to single-stranded DNA: sequence specificity and hemi-intercalation model from fluorescence and 1H NMR spectroscopy. J. Mol. Biol. 1996, 262: 53-68. 10.1006/jmbi.1996.0498.CrossRefPubMed
12.
go back to reference Lenz HJ, Danenberg K, Schnieders B, Goeker E, Peters GJ, Garrow T, Shane B, Bertino JR, Danenberg PV: Quantitative analysis of folylpolyglutamate synthetase gene expression in tumor tissues by polymerase chain reaction: marked variation of expression among leukemia patients. Oncol. Res. 1994, 6: 329-335.PubMed Lenz HJ, Danenberg K, Schnieders B, Goeker E, Peters GJ, Garrow T, Shane B, Bertino JR, Danenberg PV: Quantitative analysis of folylpolyglutamate synthetase gene expression in tumor tissues by polymerase chain reaction: marked variation of expression among leukemia patients. Oncol. Res. 1994, 6: 329-335.PubMed
13.
go back to reference Villarete LH, Remick DG: Transcriptional and post-transcriptional regulation of lnterleukin-8. Am. J. Pathol. 1996, 149: 1685-1693.PubMedCentralPubMed Villarete LH, Remick DG: Transcriptional and post-transcriptional regulation of lnterleukin-8. Am. J. Pathol. 1996, 149: 1685-1693.PubMedCentralPubMed
14.
go back to reference DePonti-Zilli L, Seiler-Tuyns A, Paterson BM: A 40-base-pair sequence in the 3' end of the beta-actin gene regulates beta-actin mRNA transcription during myogenesis. Proc. Natl. Acad. Sci. USA. 1988, 85: 1389-1393.PubMedCentralCrossRefPubMed DePonti-Zilli L, Seiler-Tuyns A, Paterson BM: A 40-base-pair sequence in the 3' end of the beta-actin gene regulates beta-actin mRNA transcription during myogenesis. Proc. Natl. Acad. Sci. USA. 1988, 85: 1389-1393.PubMedCentralCrossRefPubMed
15.
go back to reference Sympson CJ, Geoghegan TE: Actin gene expression in murine erythroleukemia cells treated with cytochalasin D. Experimental Cell Research. 1990, 189: 28-32.CrossRefPubMed Sympson CJ, Geoghegan TE: Actin gene expression in murine erythroleukemia cells treated with cytochalasin D. Experimental Cell Research. 1990, 189: 28-32.CrossRefPubMed
16.
go back to reference Leclerc GJ, Barredo JC: Folylpoly-γ-glutamate synthetase gene mRNA splice variants and protein expression in primary human leukemia cells, cell lines, and normal human tissues. Clin. Cancer Res. 2001, 7: 942-951.PubMed Leclerc GJ, Barredo JC: Folylpoly-γ-glutamate synthetase gene mRNA splice variants and protein expression in primary human leukemia cells, cell lines, and normal human tissues. Clin. Cancer Res. 2001, 7: 942-951.PubMed
Metadata
Title
Real-time RT-PCR analysis of mRNA decay: half-life of Beta-actin mRNA in human leukemia CCRF-CEM and Nalm-6 cell lines
Authors
Guy J Leclerc
Gilles M Leclerc
Julio C Barredo
Publication date
01-12-2002
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2002
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/1475-2867-2-1

Other articles of this Issue 1/2002

Cancer Cell International 1/2002 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine